Report DescriptionAbout IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Peripheral Artery Disease Market Research Report:
The latest report by IMARC, titled “ PeripheralArteryDiseaseMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandFore cast2023-2028
” " finds that the global peripheral artery disease market size reached US$ 4.4 Billion in 2022.
Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It is caused when plaque, or atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It can cause hair loss, feet or toe sores, leg numbness, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction in men. At present, PAD is diagnosed through the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).
Request Free Sample Report:
https://www.imarcgroup.com/peripheral-artery-disease-market/requestsample
Report Description Report Description and Highlights
Global Peripheral Artery Disease Market Trends:
The market is primarily driven by the rising geriatric population across the globe. In addition, changing lifestyles of individuals due to unhealthy dietary patterns, alcoholism, and lack of physical activities represent another major growth-inducing factor. Besides this, individuals are widely opting for minimally invasive (MI) surgeries due to less postoperative pain, shortened hospital stay, fewer operative and major postoperative complications, faster recovery times, and less stress on the immune system.
This, coupled with the growing prevalence of cardiac diseases among the masses, is positively influencing market growth. Moreover, the expanding healthcare industry and increasing mergers and acquisitions (M&A) and developmental strategies amongst key players are also creating a favorable market outlook across the globe. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a CAGR of 5.94% during 20232028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Report Description Report Description and Highlights
MarketSummary:
BreakupbyType:
• Peripheral Angioplasty Balloons
• Peripheral Stents
• Peripheral Catheters
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Peripheral Accessories
BreakupbyEndUser:
• Hospitals
• Specialty Clinics
• Others
BreakupbyRegion:
• North America
• United States
Report Description Report Description and Highlights
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
Report Description Report Description and Highlights
• Others
• Middle East and Africa
CompetitiveLandscapewithKeyPlayers:
• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical LLC
• Koninklijke Philips N.V.
• Medtronic plc
• Terumo Corporation.
ViewFullReportwithTOC&ListofFigure:
https://www.imarcgroup.com/peripheral-artery-disease-market
A partial List of our Clients
Partial List of Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions
A partial List of our Clients
Partial List of Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions
Report Description Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.